Pediatrix Medical Group Q3 revenue slightly beats on volume and pricing
Overview
US physician services provider's Q3 revenue slightly beat analyst expectations, rising 1.7% yr/yr
Q3 adjusted EBITDA beat analyst expectations
Company says results driven by volume and pricing ahead of expectations
Outlook
Pediatrix expects full-year 2026 Adjusted EBITDA between $290 mln and $300 mln
Result Drivers
VOLUME AND PRICING - Co said Q3 results were driven by both patient volume and pricing performing ahead of expectations, per CEO Mark S. Ordan
RECENT ACQUISITIONS - Co said growth in non-same unit activity was driven by recent acquisitions, partially offset by practice dispositions
FAVORABLE PAYOR MIX - Co said same-unit revenue from net reimbursement-related factors increased due to a favorable shift in payor mix, higher administrative fees from hospital partners and higher patient acuity, primarily in neonatology
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Slight Beat* | $501.37 mln | $498.14 mln (7 Analysts) |
Q3 Net Income | $46.99 mln | ||
Q3 Adjusted EBITDA | Beat | $85.48 mln | $80.10 mln (7 Analysts) |
Q3 Income from operations | $65.21 mln | ||
Q3 Operating Expenses | $436.16 mln |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Pediatrix Medical Group Inc is $28.00, about 3.1% below its October 28 closing price of $28.91
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 11 three months ago
Reuters Recommended Reads
Oct 27 - Universal Health warns of possible impact to annual results from Medicaid changes; Q3 revenue slightly beats
Oct 27 - Ensign Group Q3 adjusted EPS beats estimates, revenue up on higher occupancy rates
Oct 27 - HCA signals flat 2027 earnings as Medicaid payments drop; shares slide
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)